Biocon Secures Health Canada Approval For Two Denosumab Biosimilars

Bosaya And Vevzuo Set To Compete With Prolia And Xgeva

 
• By Anabel Costa-Ferreira
  
Health Canada sign
(Shutterstock)

More from Biosimilars

More from Generics Bulletin